To study the role of TGF-β in tumor development, we previously developed a mouse model of SCC that harbors an in vivo fluorescent reporter and lineage tracing system for the TGF-β–SMAD2/3 signaling pathway (Oshimori et al, 2015). The gene discussed is TGFB1; the disease is neoplasm.